Biomedical sciences industry is the fourth pillar of the country’s manufacturing economy and is extensively fostering local R&D and startups to boost innate innovations. In 2016, the Singapore government committed to a S$4 billion budget to drive research and commercialisation activities in the health and biomedical sciences sector. Further supporting the initiative, Enterprise Singapore Enterprise(SG), the statutory board of the Singapore Ministry of Trade and Industry plays a vital role in supporting local startup ecosystems. In an interaction with BioSpectrum Asia, Audrey Lok, Director of Healthcare and Biomedical, EnterpriseSG shared insights on its role in promoting Singapore as an Asia-Pacific hub for startups and innovations. Edited excerpts;
How conducive is Singapore's startup ecosystem for fostering bioscience initiatives and empowering entrepreneurship?
COVID-19 has rapidly accelerated the pace of medical innovation and transformation, and it comes as no surprise that we now have more investors and startups in this sector. As of 2021, 400 biomedical startups and SMEs in Singapore prioritise innovative solutions that address today’s healthcare needs or ones that address the pandemic. 1.3 billion in biomedical investments across 40 deals have been recorded in the same year.
A part of this success can be attributed to the thriving ecosystem built upon strong public-private partnerships. Our public healthcare clusters have enabled many healthcare and biomedical startups to embrace innovation, by tapping the clinical strengths and expertise of our healthcare system to refine, develop and testbed solutions. In fact, they have been supporting more than 100 industry engagements and facilitations every year. They are also critical partners who identify
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
"We are dedicated to helping people of all ages see brilliantly"
The global leader in eye care for over 75 years, Alcon Inc. strives to help eye care professionals strengthen their practices and serve patients better, improving visual health worldwide. Through its innovative eye care portfolios, Alcon has established operations in 56 countries and serves patients in 140 countries. Jason Hoffe, Vice President, APAC Vision Care, Alcon, responsible for driving the vision care business in the region shares opportunities exist for the company and new developments in eye healthcare that are cause for optimism for patients in the region.
Singapore Turns Tech Beacon with Revolutionary Pharma Manufacturing & Digital Transformation
In the current pharmaceutical manufacturing environment, linking information technology (IT) with operational technology (OT) systems is increasingly vital. This integration enables a seamless exchange of information between these two historically separate domains - one focused on data management and the other on overseeing physical operations. This enables various aspects of the manufacturing process to gain insights from one another to boost efficiency and refine strategic decision-making. Digital transformation is essential for directing companies through the complexities of implementation and ensuring a seamless shift to a data-driven, digitally optimized manufacturing landscape.
Building the Future of Medicine
PRODUCT OF THE YEAR 2024 - Needle Free Injection System technology by IntegriMedical
Emerging Leader in Cell & Gene Therapy
STARTUP OF THE YEAR 2024 - ImmunoACT
Improving Access for Respiratory Healthcare
STARTUP OF THE YEAR 2024 - Aevice Health
Making an Impact with a 'CliKX'
Dr Lynne Lim, Co-Founder & Chief Executive Officer, NousQ
Eyeing 20-20 Vision of Excellence
Dr Jogin Desai, Co-Founder & Chief Executive Officer, Eyestem Research
Refining the Use of Radiation
Dr Christian Behrenbruch, Managing Director and Group Chief Executive Officer (CEO), Telix Pharmaceuticals
Honouring Innovators in Asia's Thriving Life Sciences Sector
Asia has, indeed, become the new hub for growth and innovation, with no signs of losing steam. To recognise the Asian companies and individuals for their commendable performance and achievements during 2023 and 2024, BioSpectrum Asia Excellence Awards 2024 ceremony was held at Hotel Fort Canning in Singapore on December 6, 2024.
How To Control Indian Diabetes Growth
World Diabetes Day, observed on November 14, reminds us of the growing impact of diabetes on global health and the urgent need for collective action to prevent, diagnose, and manage this chronic condition. In 2024, the theme 'Breaking Barriers, Bridging Gaps' underscores the critical importance of accessible, high-quality diabetes care, especially for underrepresented communities. The Government of India has taken many measures intending to reduce the prevalence of diabetes and alleviate its long-term complications, contributing to a healthier future for all citizens.
